Fluid therapy and the hypovolemic microcirculation

Current Opinion in Critical Care

Volumn 21, Issue 4, 2015, Pages 276-284

  Gruartmoner, G ^a   Mesquida, J ^a   Ince, Can ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fluid therapy; Goal directed therapy; Hypovolemia; Microcirculation; Shock

Indexed keywords

FLUID THERAPY; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; HYPOVOLEMIC MICROCIRCULATION; MICROCIRCULATION; RESUSCITATION; REVIEW; TIME; TISSUE PERFUSION; ADVERSE EFFECTS; INTENSIVE CARE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SHOCK;

CRITICAL CARE; FLUID THERAPY; HEMODYNAMICS; HUMANS; HYPOVOLEMIA; MICROCIRCULATION; SHOCK;

EID: 84942873516     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000220     Document Type: Review

References (61)

1. Vincent JL, De Backer D. Circulatory shock. N Engl J Med 2013; 369:1726-1734.
2. Mesquida J, Borrat X, Lorente JA, et al. Objectives of hemodynamic resuscitation. Med Intensiva 2011; 35:499-508.
3. Gruratmoner G, Mesquida J, Ince C. How can we monitor microcirculation in sepsis? Does it improve outcome In: Deutschman CS, Neligan PJ, editors. Evidence-based practice of critical care 2nd ed. Saunders; 2015 (in press).
4. Vincent JL, Ince C, Bakker J. Clinical review: circulatory shock-An update: a tribute to Professor Max Harry Weil. Crit Care 2012; 16:239.
5. Goldman D, Bateman RM, Ellis CG. Effect of decreased O2 supply on skeletal muscle oxygenation and O2 consumption during sepsis: role of heterogeneous capillary spacing and blood flow. Am J Physiol Heart Circ Physiol 2006; 290:H2277-H2285.
6. Chappell D, Westphal M, Jacb M, et al. The impact of glycocalix on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22:155-162.
7. Bezemer R, Bartels SA, Bakker J, et al. Clinical review: Clinical imaging of the sublingual microcirculation in the critically ill-where do we stand Crit Care 2012; 16:224-228.
8. Weil MH, Tang W. Welcoming a new era of hemodynamic monitoring: expanding from the macro to the microcirculation. Crit Care Med 2007; 35:1203-1204.
9. De Backer D, Orbegozo D, Donadello K, et al. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence 2014; 5:73-79.
10. Perner A, De Backer D. Understanding hypovolemia. Intensive Care Med 2014; 40:613-615.
11. Ince C. The rationale for microcirculatory-guided fluid therapy. Curr Opin Crit Care 2014; 20:301-308.
12. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999; 27:1369-1377.
13. Antonelli M, Levy M, Andrews PJD, et al. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med 2007; 33:575-590.
14. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36:222-231.
15. De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104.
16. Sakr Y, Dubois MJ, De Backer D, et al. Persistant microvasculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831.
17. Mesquida J, Espinal C, Gruartmoner G, et al. Prognostic implications of tissue oxygen saturation in human septic shock. Intensive Care Med 2012; 38:592-597.
18. Poeze M, Solberg B, Greve JW, et al. Monitoring global volume-related hemodynamic or regional variables after initial resuscitation: what is a better predictor of outcome in critically ill septic patients? Crit Care Med 2005; 33:2494-2500.
19. Levy B, Gawalkiewicz P, Vallet B, et al. Gastric capnometry with air-Automated tonometry predicts outcome in critically ill patients. Crit Care Med 2003; 31:474-480.
20. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40:1795-1815.
21. Pottecher J, Deruddre S, Teboul JL, et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intensive Care Med 2010; 36:1867-1874.
22. Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med 2010; 36:949-955.
23. Pranskunas A, Koopmans M, Koetsier PM, et al. Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med 2013; 39:612-619.
24. Silva E, De Backer D, Creteur J, Vincent JL. Effects of fluid challenge on gastric mucosal pCO2 in septic patients. Intensive Care Med 2004; 30:423-429.
25. Hanson JP, Lam SW, Mohanty S, et al. Fluid resuscitation of adults with severe falciparum malaria: effects on acid-base status, renal function, and extravascular lung water. Crit Care Med 2013; 41:972-981.
26. Maitland K, Kiguli S, Opoka RO, et al. FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495.
27. Vellinga NAR, Ince C, Boerma EC. Elevated central venous pressure is associated with impairment of microcirculatory blood flow in sepsis: a hypothesis generating post hoc analysis. BMC Anesthesiol 2013; 13:17.
28. Dellinger RP, Levy MM, Rhodes A, et al., The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med 2013; 39:165-228.
29. Mesquida J. Evaluating tissue oxygenation at the bedside: global, regional, or both? J Clin Monit Comput 2015. [Epub ahead of print]
30. Aykut G, Veenstra G, Scorcella C, et al. Cytocam-IDF (incident dark field illumination) imaging for bedside monitoring of the microcirculation. Intensive Care Med Exp 2015; 3:4.
31. Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39:259-265.
32. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025-1032.
33. Kern JW, Shoemaker WC. Meta-Analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002; 30:1686-1692.
34. Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
35. Ferrer R, Artigas A, Levy MM, et al. Edusepsis Study Group. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299:2294-2303.
36. Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009; 136:102-109.
37. Ince C. The great fluid debate: when will physiology prevail Anesthesiology 2013; 119:248-249.
38. Raghunathan K, Murray PT, Beattie WS, et al. Choice of fluid in acute illness: what should be given an international consensus. Br J Anaesth 2014; 113:772-783.
39. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369:1243-1251.
40. Woodcock TE, Woodcock TM. Revised starling equation and the glycocalix model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012; 108:384-394.
41. Konrad FM, Mik EG, Bodmer SIA, et al. Acute normovolemic hemodilution in the pig is associated with renal tissue edema, impaired renal microvascular oxygenation, and functional loss. Anesthesiology 2013; 119: 256-269.
42. Johaness T, Mik EG, Nohé B, et al. Influence of fluid resuscitation on renal microvascular PO2 in a normotensive rat model of endotoxemia. Crit Care 2006; 10:R88.
43. Guidet B, Martinet O, Boilain T, et al. Assessment of hemodynamic efficacy and safety of 0.6%hydroxyethylstarch 130/0.4 vs. 0.9%NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012; 16:R94.
44. James MF, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial. Br J Anaesth 2011; 107: 693-702.
45. Dubin A, Pozo MO, Casabella CA, et al. Comparison of 6%hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010; 25:659; e1-8.
46. Dart AB, Mutter TC, Ruth CA, et al. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; CD007594.
47. Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-Analysis and trial sequential analysis. Br Med J 2013; 346:839.
48. Neuhaus W, Schick MA, Bruno RR, et al. The effects of colloid solutions on renal proximal tubular cells in vitro. Anesth Analg 2012; 114:371-374.
49. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911.
50. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's actetate in severe sepsis. N Engl J Med 2012; 367:124-134.
51. Annane D, Siami S, Jaber S, et al. CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013; 310:1809-1817.
52. Pharmacovigilance Risk Assessment Committee of the European Medicines Agency. Available http://www.ema.europa.eu/docs/en-GB/document-library/Press-release/2013/06/WC500144446.pdf (accessed four July 2013).
53. Hydroxyethyl-starch solutions (HES) no longer to be used in patients with sepsis or burn injuries or in critically ill patients. European Medicines Agency. 19 December 2013. EMA/809470/2013. in press.
54. Caironi P, Tognoni G, Masson S, et al. ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370:1412-1421.
55. Meybohm P, Aken HV, Gasperi AD, et al. Re-evaluating currently avaliable data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients-A multidisciplinary statement. Crit Care 2013; 17:R166.
56. Ince C, Groenveld AB. The case for 0.9%NaCl: is the undefendable, defensible Kidney Int 2014; 86:1087-1095.
57. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth 2008; 101:141-150.
58. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566-1572.
59. Legrand M, Mik EG, Balestra GM, et al. Fluid resuscitation does not improve renal oxygenation during hemorrhagic shock in rats. Anesthesiology 2010; 112:119-127.
60. Van Iterson M, Siegemund M, Burhop K, et al. Hemoglobin-based oxygen carrier provides heterogeneous microvascular oxygenation in heart and gut after hemorrhage in pigs. J Trauma 2003; 55:1111-1124.
61. Legrand M, Bezemer R, Kandil A, et al. The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med 2011; 37:1534-1542.